Kitov Pharma Ltd. Sponsored ADR

( )
KTOV After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
JNJJohnson & Johnson
PFEPfizer Inc.
ABBVAbbVie, Inc.
MRKMerck & Co., Inc.
BMYBristol-Myers Squibb Company
LLYEli Lilly and Company
NVSNovartis AG Sponsored ADR
AZNAstraZeneca PLC Sponsored ADR
GSKGlaxoSmithKline plc Sponsored ADR
NVONovo Nordisk A/S Sponsored ADR Class B
SNYSanofi Sponsored ADR
LCILannett Company, Inc.
AKTXAkari Therapeutics Plc Sponsored ADR

Company Profile

Kitov Pharma Ltd. is a development stage biopharmaceutical company, which engages in drug development. The firm offers Consensi and NT219. Consensi is intended to treat osteoarthritis pain and hyper tension simultaneously, while NT219 is a cancer therapy drug that delivers anti-tumor effects and increasing survical in various cancer models. The company was founded by John Paul Waymack in June 2010 and is headquartered in Tel Aviv, Israel.